Serina Therapeutics, Inc.
SER
$5.70
-$0.15-2.56%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.67M | 3.19M | 6.06M | 8.71M | 7.62M |
Total Receivables | -- | 14.00K | 51.00K | 65.00K | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.93M | 2.08M | 2.80M | 166.00K | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 77.00K | 143.00K | -- | -- | -- |
Total Current Assets | 5.68M | 5.42M | 8.92M | 8.94M | 7.62M |
|
|||||
Total Current Assets | 5.68M | 5.42M | 8.92M | 8.94M | 7.62M |
Net Property, Plant & Equipment | 1.05M | 1.12M | 1.20M | 1.30M | 1.35M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | 509.00K | 541.00K | 574.00K | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 383.00K | 50.00K | 50.00K | -- |
Total Assets | 6.72M | 7.44M | 10.71M | 10.86M | 8.97M |
|
|||||
Total Accounts Payable | 744.00K | 1.70M | 1.20M | 2.61M | 580.00K |
Total Accrued Expenses | 1.43M | 1.16M | 769.00K | 1.41M | 583.00K |
Short-term Debt | -- | 10.46M | 10.45M | 9.75M | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 193.00K | 198.00K | 211.00K | 231.00K | 250.00K |
Total Finance Division Other Current Liabilities | -- | -- | 5.00K | 69.00K | -- |
Total Other Current Liabilities | -- | -- | 5.00K | 69.00K | -- |
Total Current Liabilities | 2.37M | 13.51M | 12.63M | 14.06M | 1.41M |
|
|||||
Total Current Liabilities | 2.37M | 13.51M | 12.63M | 14.06M | 1.41M |
Long-Term Debt | -- | 693.00K | 693.00K | 693.00K | 2.98M |
Short-term Debt | -- | 10.46M | 10.45M | 9.75M | -- |
Capital Leases | 268.00K | 312.00K | 362.00K | 413.00K | 462.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.58M | 6.74M | 13.41M | -- | -- |
Total Liabilities | 6.22M | 21.26M | 27.10M | 15.17M | 4.86M |
|
|||||
Common Stock & APIC | 44.96M | 8.00M | 6.82M | 1.13M | 883.00K |
Retained Earnings | -44.32M | -21.78M | -23.19M | -5.44M | -33.18M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 641.00K | -13.77M | -16.36M | -4.31M | -32.29M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 36.40M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | 36.40M |
|
|||||
Total Common Equity | 641.00K | -13.77M | -16.36M | -4.31M | -32.29M |
Total Preferred Equity | -- | -- | -- | -- | 36.40M |
Total Minority Interest | -133.00K | -54.00K | -30.00K | -- | -- |
Total Equity | 508.00K | -13.83M | -16.39M | -4.31M | 4.11M |
|